Literature DB >> 15112359

Effect of cyclin G2 on proliferative ability of SGC-7901 cell.

Jie Liu1, Ze-Shi Cui, Yang Luo, Li Jiang, Xiao-Hui Man, Xue Zhang.   

Abstract

AIM: To study the effect of cyclin G2 on proliferation of gastric adenocarcinoma cell line-SGC-7901 cell in vitro.
METHODS: By use of cation lipofectamine transfection reagent, the pIRES-G2 and pIRESneo plasmids were transferred into SGC-7901cell line. Anticlones were selected by G418. Positive clones were observed and counted using Giemsa staining. Cell proliferative ability was assayed by MTT.
RESULTS: (1) The clone number of pIRES-G2 group decreased, clone volume reduced. The number of cell clones in pIRESneo group was 87+/-3, that of pIRES-G2 group was 53+/-4, occupying 60.1% of pIRESneo group, there was significant difference obviously (P<0.01, t=15.45). (2) The average absorbance of clone cell obtained by stable transfection of pIRES-G2 at 570 nm was 1.6966+/-0.2125, the average absorbance of clone cell obtained by stable transfection of pIRESneo at 570 nm was 2.1182+/-0.3675, there was significant difference between them (P<0.01, t=3.412).
CONCLUSION: Cyclin G2 can inhibit SGC-7901cell proliferative ability obviously, it may be a negative regulator in cell cycle regulation.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15112359      PMCID: PMC4622783          DOI: 10.3748/wjg.v10.i9.1357

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  19 in total

1.  pIRES-CD4t, a dicistronic expression vector for MACS- or FACS-based selection of transfected cells.

Authors:  P Gaines; D M Wojchowski
Journal:  Biotechniques       Date:  1999-04       Impact factor: 1.993

2.  Cyclin G2 is up-regulated during growth inhibition and B cell antigen receptor-mediated cell cycle arrest.

Authors:  M C Horne; K L Donaldson; G L Goolsby; D Tran; M Mulheisen; J W Hell; A F Wahl
Journal:  J Biol Chem       Date:  1997-05-09       Impact factor: 5.157

3.  Cyclin-dependent kinases: a new cell cycle motif?

Authors:  J Pines; T Hunter
Journal:  Trends Cell Biol       Date:  1991-11       Impact factor: 20.808

4.  Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression.

Authors:  M C Horne; G L Goolsby; K L Donaldson; D Tran; M Neubauer; A F Wahl
Journal:  J Biol Chem       Date:  1996-03-15       Impact factor: 5.157

5.  Gene structure and chromosomal localization of mouse cyclin G2 (Ccng2).

Authors:  M R Jensen; T Audolfsson; C L Keck; D B Zimonjic; S S Thorgeirsson
Journal:  Gene       Date:  1999-04-16       Impact factor: 3.688

Review 6.  Cyclins and cyclin-dependent kinases: theme and variations.

Authors:  J Pines
Journal:  Adv Cancer Res       Date:  1995       Impact factor: 6.242

7.  Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery.

Authors:  S H Kimura; M Ikawa; A Ito; M Okabe; H Nojima
Journal:  Oncogene       Date:  2001-05-31       Impact factor: 9.867

8.  Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling.

Authors:  C C Wykoff; C W Pugh; P H Maxwell; A L Harris; P J Ratcliffe
Journal:  Oncogene       Date:  2000-12-14       Impact factor: 9.867

9.  Cationic lipids enhance cellular uptake and activity of phosphorothioate antisense oligonucleotides.

Authors:  C F Bennett; M Y Chiang; H Chan; J E Shoemaker; C K Mirabelli
Journal:  Mol Pharmacol       Date:  1992-06       Impact factor: 4.436

10.  Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1.

Authors:  K Tamura; Y Kanaoka; S Jinno; A Nagata; Y Ogiso; K Shimizu; T Hayakawa; H Nojima; H Okayama
Journal:  Oncogene       Date:  1993-08       Impact factor: 9.867

View more
  7 in total

1.  Recruitment of cyclin G2 to promyelocytic leukemia nuclear bodies promotes dephosphorylation of γH2AX following treatment with ionizing radiation.

Authors:  Yoko Naito; Norikazu Yabuta; Jun Sato; Shouichi Ohno; Muneki Sakata; Takashi Kasama; Masahito Ikawa; Hiroshi Nojima
Journal:  Cell Cycle       Date:  2013-05-08       Impact factor: 4.534

2.  Cyclin G2 is degraded through the ubiquitin-proteasome pathway and mediates the antiproliferative effect of activin receptor-like kinase 7.

Authors:  Guoxiong Xu; Stefanie Bernaudo; Guodong Fu; Daniel Y Lee; Burton B Yang; Chun Peng
Journal:  Mol Biol Cell       Date:  2008-09-10       Impact factor: 4.138

3.  Cyclin G2 inhibits epithelial-to-mesenchymal transition by disrupting Wnt/β-catenin signaling.

Authors:  S Bernaudo; M Salem; X Qi; W Zhou; C Zhang; W Yang; D Rosman; Z Deng; G Ye; B B Yang; B Vanderhyden; Z Wu; C Peng
Journal:  Oncogene       Date:  2016-02-15       Impact factor: 9.867

4.  Epidermal growth factor promotes cyclin G2 degradation via calpain-mediated proteolysis in gynaecological cancer cells.

Authors:  Stefanie Bernaudo; Shahin Khazai; Eilyad Honarparvar; Alina Kopteva; Chun Peng
Journal:  PLoS One       Date:  2017-06-22       Impact factor: 3.240

5.  Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis.

Authors:  Lan Li; Yu Cao; Hourong Zhou; Yu Li; Bing He; Xia Zhou; Zhao Nie; Li Liang; Ying Liu; Limin Ye
Journal:  Onco Targets Ther       Date:  2018-10-26       Impact factor: 4.147

6.  Cyclin G2 Inhibits the Warburg Effect and Tumour Progression by Suppressing LDHA Phosphorylation in Glioma.

Authors:  Sen Li; Jinlan Gao; Xinbin Zhuang; Chenyang Zhao; Xiaoyu Hou; Xuesha Xing; Chen Chen; Qi Liu; Shuang Liu; Yang Luo
Journal:  Int J Biol Sci       Date:  2019-01-01       Impact factor: 6.580

7.  Cyclin G2 suppresses estrogen-mediated osteogenesis through inhibition of Wnt/β-catenin signaling.

Authors:  Jinlan Gao; Qi Liu; Xing Liu; Chunyan Ji; Shengqiang Qu; Shusen Wang; Yang Luo
Journal:  PLoS One       Date:  2014-03-03       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.